Formulation and biopharmaceutical evaluation of risperidone loaded chitosan nanoparticles for intranasal delivery.
CONCLUSION: Risperidone loaded chitosan nanoparticles were effective against schizophrenia via intranasal route.
PMID: 31094571 [PubMed - as supplied by publisher]
Source: Drug Development and Industrial Pharmacy - Category: Drugs & Pharmacology Tags: Drug Dev Ind Pharm Source Type: research
More News: Amphetamine | Brain | Drugs & Pharmacology | Nanotechnology | Neurology | Risperdal Consta | Schizophrenia